Schmid-Elsaesser, R <br/><br/>
Monotherapy with dextromethorphan or tirilazad--but not a combination of both--improves outcome after transient focal cerebral ischemia in rats.  [electronic resource] 

 -  Experimental brain research  Sep 1998 
 - 121-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-4819 
<br/><br/><label>Standard No.: </label>10.1007/s002210050498  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Calcium Channel Blockers--therapeutic use<br/>Cerebral Infarction--pathology<br/>Dextromethorphan--therapeutic use<br/>Drug Evaluation, Preclinical<br/>Drug Therapy, Combination<br/>Excitatory Amino Acid Antagonists--therapeutic use<br/>Ischemic Attack, Transient--drug therapy<br/>Laser-Doppler Flowmetry<br/>Male<br/>Neuroprotective Agents--therapeutic use<br/>Pregnatrienes--therapeutic use<br/>Rats<br/>Rats, Sprague-Dawley<br/>Treatment Outcome<br/>Weight Gain--drug effects